• Something wrong with this record ?

Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia

J. Mayer, P. Čičátková, L. Kováčová, M. Jarošová, M. Karas, P. Jindra, H. Klamová, KM. Poláková, O. Černá, E. Cmunt, P. Bělohlávková, P. Žák, E. Faber, T. Papajík, L. Stejskal, I. Ježíšková, B. Weinbergerová, T. Jurček, T. Horňák, D. Žáčková, Š....

. 2025 ; 100 (4) : 729-734. [pub] 20250128

Language English Country United States

Document type Letter, Journal Article

Persistent link   https://www.medvik.cz/link/bmc25009366

Grant support
The National Institute for Cancer Research Project (Programme EXCELES, ID Project No. LX22NPO5102
The CzEch Leukemia Study Group for Life, CELL

The influence of t(v;22) sole, major route ACAs all (+8, n = 14; +Ph, n = 10; +19, n = 1), and -Y sole on progression-free survival. Survival curves are compared with those of patients with the standard t(9;22) translocation. Other ACAs or complex karyotypes did not influence survival.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009366
003      
CZ-PrNML
005      
20250429134455.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ajh.27608 $2 doi
035    __
$a (PubMed)39873232
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mayer, Jiří $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000305679887 $7 nlk20000083651
245    10
$a Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia / $c J. Mayer, P. Čičátková, L. Kováčová, M. Jarošová, M. Karas, P. Jindra, H. Klamová, KM. Poláková, O. Černá, E. Cmunt, P. Bělohlávková, P. Žák, E. Faber, T. Papajík, L. Stejskal, I. Ježíšková, B. Weinbergerová, T. Jurček, T. Horňák, D. Žáčková, Š. Ransdorfová, M. Holzerová, T. Pavlík
520    9_
$a The influence of t(v;22) sole, major route ACAs all (+8, n = 14; +Ph, n = 10; +19, n = 1), and -Y sole on progression-free survival. Survival curves are compared with those of patients with the standard t(9;22) translocation. Other ACAs or complex karyotypes did not influence survival.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a chronická myeloidní leukemie $x genetika $x diagnóza $x mortalita $7 D015464
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a translokace genetická $7 D014178
650    _2
$a dospělí $7 D000328
650    _2
$a prognóza $7 D011379
650    12
$a chromozomální aberace $7 D002869
650    _2
$a senioři $7 D000368
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a lidské chromozomy, pár 22 $x genetika $7 D002892
650    _2
$a lidské chromozomy, pár 9 $x genetika $7 D002899
655    _2
$a dopisy $7 D016422
655    _2
$a časopisecké články $7 D016428
700    1_
$a Čičátková, Petra $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000274127544
700    1_
$a Kováčová, Lenka $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic
700    1_
$a Jarošová, Marie $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000221943433
700    1_
$a Karas, Michal $u Department of Hematology and Oncology, University Hospital Plzeň, Plzeň, Czech Republic $1 https://orcid.org/0000000177358412
700    1_
$a Jindra, Pavel $u Department of Hematology and Oncology, University Hospital Plzeň, Plzeň, Czech Republic $1 https://orcid.org/0000000284157069 $7 xx0098857
700    1_
$a Klamová, Hana $u Institute of Hematology and Blood Transfusion, Praha, Czech Republic $1 https://orcid.org/0009000050207040 $7 xx0081721
700    1_
$a Poláková, Kateřina Machová $u Institute of Hematology and Blood Transfusion, Praha, Czech Republic $1 https://orcid.org/0000000273985555 $7 xx0139783
700    1_
$a Černá, Olga $u Department of Hematology, University Hospital Královské Vinohrady, Praha, Czech Republic $1 https://orcid.org/0000000334305104 $7 mzk2008430780
700    1_
$a Cmunt, Eduard $u Department of Internal medicine, Hematology, General University Hospital, Praha, Czech Republic $1 https://orcid.org/0000000164867402 $7 xx0106898
700    1_
$a Bělohlávková, Petra $u Department of Internal Medicine IV, Hematology, University Hospital Hradec Králové, Hradec Králové, Czech Republic $1 https://orcid.org/0000000187287443
700    1_
$a Žák, Pavel $u Department of Internal Medicine IV, Hematology, University Hospital Hradec Králové, Hradec Králové, Czech Republic $1 https://orcid.org/0000000344655343
700    1_
$a Faber, Edgar $u Department of Hematology-Oncology, University Hospital Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000232597791 $7 xx0062699
700    1_
$a Papajík, Tomáš $u Department of Hematology-Oncology, University Hospital Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000157791139 $7 xx0060566
700    1_
$a Stejskal, Lukáš $u Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Ježíšková, Ivana $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000187607718 $7 mzk2005318075
700    1_
$a Weinbergerová, Barbora $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000164602471
700    1_
$a Jurček, Tomáš $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000252837406
700    1_
$a Horňák, Tomáš $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000270033372
700    1_
$a Žáčková, Daniela $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000198028148 $7 xx0074334
700    1_
$a Ransdorfová, Šárka $u Institute of Hematology and Blood Transfusion, Praha, Czech Republic $1 https://orcid.org/000000024272060X
700    1_
$a Holzerová, Milena $u Department of Hematology-Oncology, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Pavlík, Tomáš $u Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/000000017166032X
773    0_
$w MED00000251 $t American journal of hematology $x 1096-8652 $g Roč. 100, č. 4 (2025), s. 729-734
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39873232 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134451 $b ABA008
999    __
$a ok $b bmc $g 2311004 $s 1246447
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 100 $c 4 $d 729-734 $e 20250128 $i 1096-8652 $m American journal of hematology $n Am J Hematol $x MED00000251
GRA    __
$p The National Institute for Cancer Research Project (Programme EXCELES, ID Project No. LX22NPO5102
GRA    __
$p The CzEch Leukemia Study Group for Life, CELL
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Archiving options